Clinical Trial Update: Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction [Phase 4]

View source ↗

Summary

Phase 4 trial comparing lanreotide Autogel and octreotide LAR in acromegaly found comparable effects on GH and IGF-I levels and patient satisfaction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Lanreotide Autogel (lanreotide)
• Octreotide LAR (octreotide long-acting release)

Snippet

Sponsor: Odense University Hospital | Conditions: Acromegaly | Phase 4 | Status: COMPLETED